The Seretide Accuhaler, also known as Advair Diskus, is a specially formulated prescription inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It combines two potent active ingredients: Fluticasone Propionate, a corticosteroid that helps to reduce inflammation in the airways, and Salmeterol Xinafoate, a long-acting beta2-adrenergic agonist (LABA) that eases breathing by relaxing the muscles around the airways. This two-in-one inhaler is designed to control and prevent respiratory symptoms such as wheezing, shortness of breath, and airflow obstruction, enhancing breathing comfort. Available in two dosage strengths of 50mcg/250mcg and 50mcg/500mcg, it provides flexibility to meet different therapeutic needs.